PEPTiPEN RETA
Metabolic
PP-RETA-10MG In Stock

PEPTiPEN RETA

Triple-Receptor GLP-1 · GIP · Glucagon Agonist

Retatrutide (LY-3437943) CAS 2381089-83-2
Volume 10 MG / 3 mL
Purity ≥98%
Grade Research
$289 Per pen · Free shipping

50 in stock

Fast Dispatch
Pharmaceutical Grade
Secure Checkout
Third-Party Tested
Retatrutide (LY-3437943) — triple-receptor peptide agonist structure

Retatrutide (LY-3437943) — triple-receptor peptide agonist structure

Triple-Receptor Mechanism

Retatrutide is a novel triple-agonist peptide designed to simultaneously activate three metabolic receptors: GLP-1R (glucagon-like peptide-1 receptor), GIPR (glucose-dependent insulinotropic polypeptide receptor), and GcgR (glucagon receptor). This tri-receptor engagement is investigated for its unique capacity to modulate energy homeostasis, appetite signalling, and hepatic glucose output through complementary pathways.

Formula LY-3437943 · C₂₂₃H₃₅₁N₅₇O₆₅

Research Applications

🔬

GLP-1R Agonism

Activates GLP-1 receptor pathways studied for appetite regulation and glucose-dependent insulin secretion in preclinical models.

⚗️

GIP Receptor Activity

Dual GIP receptor engagement investigated for its role in metabolic rate modulation and adipose tissue biology.

🧬

Glucagon Agonism

Glucagon receptor activity studied for hepatic glucose output regulation and thermogenic pathway research.

📊

Phase II Data

Published Phase II clinical trial data reported an average ~24% change in body weight parameters over 48 weeks in the trial population. Provided for scientific reference only.

  • GLP-1, GIP, and Glucagon receptor agonist — research compound
  • Studied for appetite signalling pathways in preclinical models
  • Investigated for metabolic rate pathways via glucagon receptor activity
  • Examined for glucose and insulin sensitivity markers in research settings
  • Preclinical research into body composition parameters

Compound
Specification

Sterile, research-grade compounds supplied at documented concentrations for in vitro and preclinical research.

≥98% Purity per compound
10 mg

Retatrutide (LY-3437943)

Triple-receptor peptide agonist — active research compound

CAS 2381089-83-2

Metabolic Protocol

Step 1
1 MG
Step 2
2 MG
Step 3
3 MG
Step 4
4 MG

Dose increments for research calibration only. Not prescriptive for human or animal use.

Precision Auto-Injector Pen

Precision auto-injector research pen · 0.01 mg dose increments · Stainless steel mechanism · Replaceable cartridge

0.01 mg precision increments
Replaceable research cartridge
Stainless steel mechanism
Pharmaceutical-grade materials
Sterile · Research-grade · ≥98% purity · Lyophilised
🇺🇸 MADE IN USA

Research Use Only

For laboratory research use only by qualified personnel. Not for human or veterinary use. Not for use in food, drugs, cosmetics, or household applications. Handle only in accordance with the Safety Data Sheet and applicable workplace safety requirements.